Great Point Partners’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-377,900
| Closed | -$1.57M | – | 46 |
|
|
2017
Q1 | $1.57M | Buy |
+377,900
| New | +$1.57M | 0.31% | 28 |
|
|
2014
Q4 | – | Sell |
-651,325
| Closed | -$7.5M | – | 39 |
|
|
2014
Q3 | $7.5M | Buy |
651,325
+519,358
| +394% | +$5.98M | 3.22% | 14 |
|
|
2014
Q2 | $2.57M | Sell |
131,967
-33,333
| -20% | -$648K | 1.14% | 25 |
|
|
2014
Q1 | $2.97M | Buy |
+165,300
| New | +$2.97M | 1.55% | 23 |
|